These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16420667)

  • 1. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart.
    Mao R; Wang X; Spitznagel EL; Frelin LP; Ting JC; Ding H; Kim JW; Ruczinski I; Downey TJ; Pevsner J
    Genome Biol; 2005; 6(13):R107. PubMed ID: 16420667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific transcriptional changes in human fetuses with autosomal trisomies.
    Altug-Teber O; Bonin M; Walter M; Mau-Holzmann UA; Dufke A; Stappert H; Tekesin I; Heilbronner H; Nieselt K; Riess O
    Cytogenet Genome Res; 2007; 119(3-4):171-84. PubMed ID: 18253026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21.
    Gonzales PK; Roberts CM; Fonte V; Jacobsen C; Stein GH; Link CD
    PLoS One; 2018; 13(3):e0194581. PubMed ID: 29584757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling in the adult Down syndrome brain.
    Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
    Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbations of heart development and function in cardiomyocytes from human embryonic stem cells with trisomy 21.
    Bosman A; Letourneau A; Sartiani L; Del Lungo M; Ronzoni F; Kuziakiv R; Tohonen V; Zucchelli M; Santoni F; Guipponi M; Dumevska B; Hovatta O; Antonarakis SE; Jaconi ME
    Stem Cells; 2015 May; 33(5):1434-46. PubMed ID: 25645121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dysregulated microRNAs in lymphocytes from children with Down syndrome.
    Xu Y; Li W; Liu X; Chen H; Tan K; Chen Y; Tu Z; Dai Y
    Gene; 2013 Nov; 530(2):278-86. PubMed ID: 23933415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes.
    Aït Yahya-Graison E; Aubert J; Dauphinot L; Rivals I; Prieur M; Golfier G; Rossier J; Personnaz L; Creau N; Bléhaut H; Robin S; Delabar JM; Potier MC
    Am J Hum Genet; 2007 Sep; 81(3):475-91. PubMed ID: 17701894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.
    Kahlem P; Sultan M; Herwig R; Steinfath M; Balzereit D; Eppens B; Saran NG; Pletcher MT; South ST; Stetten G; Lehrach H; Reeves RH; Yaspo ML
    Genome Res; 2004 Jul; 14(7):1258-67. PubMed ID: 15231742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.
    Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome.
    Greber-Platzer S; Schatzmann-Turhani D; Wollenek G; Lubec G
    Biochem Biophys Res Commun; 1999 Jan; 254(2):395-9. PubMed ID: 9918849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development.
    Potier MC; Rivals I; Mercier G; Ettwiller L; Moldrich RX; Laffaire J; Personnaz L; Rossier J; Dauphinot L
    J Neurochem; 2006 Apr; 97 Suppl 1():104-9. PubMed ID: 16635258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development.
    Laffaire J; Rivals I; Dauphinot L; Pasteau F; Wehrle R; Larrat B; Vitalis T; Moldrich RX; Rossier J; Sinkus R; Herault Y; Dusart I; Potier MC
    BMC Genomics; 2009 Mar; 10():138. PubMed ID: 19331679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-dosage effects in Down syndrome and trisomic mouse models.
    Gardiner K
    Genome Biol; 2004; 5(10):244. PubMed ID: 15461808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
    Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
    Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain.
    Mao R; Zielke CL; Zielke HR; Pevsner J
    Genomics; 2003 May; 81(5):457-67. PubMed ID: 12706104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of trisomic proteins in Down syndrome model systems.
    Spellman C; Ahmed MM; Dubach D; Gardiner KJ
    Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.
    Lange AW; Rothermel BA; Yutzey KE
    Dev Dyn; 2005 Jul; 233(3):954-63. PubMed ID: 15906378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.